Barry Mangum, PharmD, FCP has been named CEO of Paidion Research, Inc., a clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care). Headquartered on Leigh Farm Road in Durham, the innovative company provides its drug and device development partners comprehensive global services including pharmacometrics, innovative regulatory strategies and efficient, effective global trial execution.
Responsible for partnering with industry, government, academic and nonprofit clients to implement clinical trials for all phases of pediatric drug development, Dr. Mangum brings decades of academic and corporate pediatric clinical research expertise to the job. “Children deserve more than limited data on medicines that are being used to treat their diseases,” Dr. Mangum said. “Paidion is an organization that will energize the research community to contribute in a meaningful way to the understanding of new therapies for our next generation.”
To see how Paidion can help you meet your drug development goals as your pediatric clinical research provider, visit our recently launched website www.paidionresearch.com or contact us: email@example.com.